0000886163-20-000063.txt : 20200605
0000886163-20-000063.hdr.sgml : 20200605
20200605160752
ACCESSION NUMBER: 0000886163-20-000063
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200604
FILED AS OF DATE: 20200605
DATE AS OF CHANGE: 20200605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Berkman Charles S
CENTRAL INDEX KEY: 0001392266
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 20946207
MAIL ADDRESS:
STREET 1: 11085 NORTH TORREY PINES ROAD
STREET 2: SUITE 300
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-06-04
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001392266
Berkman Charles S
3911 SORRENTO VALLEY BOULEVARD, STE 110
SAN DIEGO
CA
92121
0
1
0
0
SVP, Gen. Counsel & Secretary
Common Stock
2020-06-04
4
S
0
11146
118.5874
D
40877
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.27 to $118.935, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Charles S. Berkman
2020-06-05